Susceptibility to moxifloxacin of pneumococci isolated in English hospitals participating in the European Antimicrobial Resistance Surveillance System (EARSS) in 2003
| Autor: | Sue Cavendish, Alan P. Johnson, Louise Bishop, Marina Warner, Theresa Lamagni, David M. Livermore, Rob George, Martin C J Wale, Georgia Duckworth, Neelam Alhaddad |
|---|---|
| Rok vydání: | 2004 |
| Předmět: |
Microbiology (medical)
Moxifloxacin Erythromycin Microbial Sensitivity Tests Penicillins medicine.disease_cause Microbiology Antibiotic resistance Streptococcus pneumoniae Drug Resistance Bacterial medicine Humans Pharmacology (medical) Antibacterial agent Aza Compounds Inpatients biology business.industry General Medicine biochemical phenomena metabolism and nutrition Antimicrobial Streptococcaceae biology.organism_classification Anti-Bacterial Agents Penicillin Infectious Diseases England Quinolines business medicine.drug Fluoroquinolones |
| Zdroj: | International journal of antimicrobial agents. 25(6) |
| ISSN: | 0924-8579 |
| Popis: | Susceptibility to moxifloxacin, penicillin and erythromycin was determined for 592 invasive Streptococcus pneumoniae collected from 20 English hospitals participating in the European Antimicrobial Resistance Surveillance System (EARSS) during 2003. Resistance to moxifloxacin, penicillin and erythromycin was observed in 0.8%, 5.4% and 13% of the isolates, respectively. These results show that the large majority of pneumococci were susceptible to moxifloxacin in 2003, the year when it was licensed for clinical use in the UK. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect